Study of ITCA 650 (Exenatide in DUROS) in Subjects With Type 2 Diabetes Mellitus
Public ClinicalTrials.gov record NCT00943917. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 2 Study of ITCA 650 in Subjects With Type 2 Diabetes Mellitus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine safety, efficacy and tolerability of various doses of ITCA 650 in subjects with type 2 diabetes.
Study identification
- NCT ID
- NCT00943917
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 155 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2009 (Type not available)
- Primary completion
- Aug 2010 (Actual)
- Completion
- Feb 2011 (Actual)
- Last update posted
- Apr 13, 2015
2009 – 2011
United States locations
- U.S. sites
- 50
- U.S. states
- 23
- U.S. cities
- 44
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Study Site | Chino | California | 91710 | — |
| Study Site | La Jolla | California | 92037 | — |
| Study Site | National City | California | 91950 | — |
| Study Site | Sacramento | California | 95821 | — |
| Study Site | San Diego | California | 92161 | — |
| Study Site | Valley Village | California | 91607 | — |
| Study Site | Longmont | Colorado | 80501 | — |
| Study Site | Pueblo | Colorado | 81001 | — |
| Study Site | Bradenton | Florida | 34203 | — |
| Study Site | Miami | Florida | 33143 | — |
| Study Site | Miami | Florida | 33169 | — |
| Study Site | Miami | Florida | 33183 | — |
| Study Site | Miramar | Florida | 33025 | — |
| Study Site | Pembroke Pines | Florida | 33026 | — |
| Study Site | St. Petersburg | Florida | 33709 | — |
| Study Site | Atlanta | Georgia | 30342 | — |
| Study Site | Sandy Springs | Georgia | 30328 | — |
| Study Site | Meridian | Idaho | 83642 | — |
| Study Site | Chicago | Illinois | 60607 | — |
| Study Site | Avon | Indiana | 46123 | — |
| Study Site | Wichita | Kansas | 67205 | — |
| Study Site | Lexington | Kentucky | 40503 | — |
| Study Site | New Orleans | Louisiana | 70112 | — |
| Study Site | Kalamazoo | Michigan | 49007 | — |
| Study Site | Traverse City | Michigan | 49684 | — |
| Study Site | Troy | Michigan | 48098 | — |
| Study Site | Ypsilanti | Michigan | 48197 | — |
| Study Site | Minneapolis | Minnesota | 55416 | — |
| Study Site | Las Vegas | Nevada | 89119 | — |
| Study Site | New Hyde Park | New York | 11042 | — |
| Study Site | Charlotte | North Carolina | 28209 | — |
| Study Site | Hickory | North Carolina | 28601 | — |
| Study Site | Cincinnati | Ohio | 45212 | — |
| Study Site | Cincinnati | Ohio | 45219 | — |
| Study Site | Franklin | Ohio | 45005 | — |
| Study Site | Kettering | Ohio | 45429 | — |
| Study Site | Norman | Oklahoma | 73069 | — |
| Study Site | Eugene | Oregon | 97404 | — |
| Study Site | Rapid City | South Dakota | 57702 | — |
| Study Site | Austin | Texas | 78749 | — |
| Study Site | Austin | Texas | 78752 | — |
| Study Site | Dallas | Texas | 75230 | — |
| Study Site | Dallas | Texas | 75251 | — |
| Study Site | Irving | Texas | 75039 | — |
| Study Site | San Antonio | Texas | 78205 | — |
| Study Site | San Antonio | Texas | 78229 | — |
| Study Site | West Jordan | Utah | 84088 | — |
| Study Site | Norfolk | Virginia | 23502 | — |
| Study Site | Olympia | Washington | 98502 | — |
| Study Site | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00943917, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 13, 2015 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00943917 live on ClinicalTrials.gov.